Vilazodone
Vilazodone is a pharmaceutical compound developed by Merck Group. It is a selective serotonin reuptake inhibitor (SSRI) and 5-HT1A receptor partial agonist used in the treatment of major depressive disorder. The core function of Vilazodone is to modulate serotonin levels in the brain to alleviate symptoms of depression.
Lab products found in correlation
2 protocols using vilazodone
Cell Cycle Regulator Expression
HPLC-DAD Analysis of Duloxetine and Vilazodone
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!